- Issuer ticker
-
BIIB
- Reported as of
-
10 Feb 2022
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
14 Feb 2022, 15:27:52 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Wendell Taylor, attorney in fact for Ginger Gregory
Key filing fact
Ginger Gregory filed Form 4 for BIOGEN INC. (BIIB) on 14 Feb 2022.
Key facts
- This page summarizes Ginger Gregory's Form 4 filing for BIOGEN INC. (BIIB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 Feb 2022, 15:27.
Change
- Previous filing in this sequence was filed on 21 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 10,028
- Date
- 10 Feb 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIIB
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +6,475
- Change %
- Price
-
$0.000000
- Shares after
- 6,475
- Date
- 10 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,475
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote